Srivastava A, Trivedi S, Kumar U, Singh Y, et al. Quality of life and cost-effectiveness of intravesical gemcitabine/docetaxel vs BCG in BCG-naive non-muscle-invasive bladder cancer. BJU Int 2025 Dec 23. doi: 10.1111/bju.70126.
PMID: 41436847